Business profile

SL.Pharma Oy

SL.Pharma Oy's registered office is Helsingfors. It is a limited company. The company was established on 2019-09-16. It operates in the industry of other human health activities n.e.c.. In its latest retained statement for 2025-12-31, revenue was €1,323,491 and operating profit was €331,171.

Business ID 3085704-8ValidUnclaimed company profile

Trusted core data

Public company details from the trade register.

Business ID
3085704-8
Sector
Other human health activities n.e.c.
Municipality
Helsingfors
Company form
Limited company
Registration date
2019-09-16
Business ID registration date
2019-09-09
Business status
Valid
Profile ownership
Unclaimed company profile

Contact and location summary

Visiting address: Ulvilantie 10 B 9, 00350, Helsingfors

About SL.Pharma Oy

Financial position and key figures for the company.

SL.Pharma Oy's location municipality is Helsingfors. It is a limited company. The company was established on 2019-09-16. It operates in the industry of other human health activities n.e.c.. In its latest retained statement for 2025-12-31, revenue was €1,323,491 and operating profit was €331,171. The latest retained financial statement for 2025-12-31 shows revenue of €1,323,491 and profit for the financial year of €263,496. Based on the latest retained statement, revenue growth was +7.9%, operating margin was +25.0%, and equity ratio was +93.3%.

Financial highlights

Key figures from the latest financial period.

Open full statement
Latest financial period

2025-12-31

Imported periods4
PRH parsed2
Profile sourcePRH/XBRL financial statement
Derived indicators
Revenue growth7.9%
Operating margin25.0%
Equity ratio93.3%
Revenue€1,323,491+€97,396 (+7.9%) vs previous periodPrevious: €1,226,094
Operating profit (loss)€331,171+€40,540 (+13.9%) vs previous periodPrevious: €290,631
Profit (loss) for the financial year€263,496+€36,261 (+16.0%) vs previous periodPrevious: €227,235
Assets€1,149,338+€193,051 (+20.2%) vs previous periodPrevious: €956,286
Balance-sheet contextLatest financial period
Other operating income€39,705Previous: €45,996
Inventory€185,676Previous: €199,424
Cash and bank€306,253Previous: €250,600
Retained earnings€808,495Previous: €651,510
Equity€1,071,991Previous: €878,745
Liabilities€77,347Previous: €77,541
Current assets€766,794Previous: €846,228
Current liabilities€77,347Previous: €77,541
Revenue trend2 periods
€1,226,094
2024-12-31
€1,323,491
2025-12-31
Operating profit (loss) trend2 periods
€290,631
2024-12-31
€331,171
2025-12-31
Profit (loss) for the financial year trend2 periods
€227,235
2024-12-31
€263,496
2025-12-31
Assets trend2 periods
€956,286
2024-12-31
€1,149,338
2025-12-31

Financial ratios

Financial ratios based on financial statement data. Source: PRH/XBRL-tilinpäätös.

Equity ratioGood
100/100 · Improving
93.3 %2024-12-31: 91.9 %
Current ratioGood
100/100 · Improving
6.36x2024-12-31: 5.80x
Operating profit marginGood
100/100 · Improving
24.3 %2024-12-31: 22.9 %
Ratio history
Ratio2024-12-312025-12-31
Equity ratio91.9 %93.3 %
Current ratio5.80x6.36x
Operating profit margin22.9 %24.3 %

Registry status and identifiers

Current registry information and identifiers based on YTJ data.

YTJ statusValid
Trade RegisterRegistered
Business ID3085704-8
VAT IDFI30857048
EU IDFIFPRO.3085704-8
MunicipalityHelsingfors
Current registered entries
2019-09-09Registered in Tax Administration (Prepayment Register)
2019-09-16Registered in Tax Administration (Tax Administration)
2019-09-16Registered in Patent and Registration Office (Trade Register)
2019-10-01VAT-liable for business activity in Tax Administration (VAT Register)

Risk certificate

An open-data based company stability and risk signal.

BUSINESS.fi

BUSINESS.fi Luottoluokitus

Profile-specific risk signal based on open data

Automatic gradeNot a credit decision
A1
ExcellentSL.Pharma Oy
Grade upgradedA3 → A1 · new analysis 2026-09-19
Model score90/100
Assessment confidenceHigh
Evidence qualityStrong financial evidenceFinancial data included
Financial trajectoryFinancial development is mostly stable or mixed.
3 comparable periods
RevenueStable
ProfitabilityStable
SolvencyStable
LiquidityImproving
Peer comparisonNational Tier 1 comparisonDescriptive comparison – does not change the model score.
675 peers
Solvency83%
Better than 83% of peers
Profitability87%
Better than 87% of peers
Liquidity89%
Better than 89% of peers
Revenue growth79%
Better than 79% of peers
Financial statement reporting patternRegularBased on observed PRH financial period end and registration dates. This descriptive evidence does not change the v0.14 score.
4 observed filings
Latest registration lag118 days after period end
Typical registration lag125 days after period end
Annual continuity4 consecutive periods
Supporting factors
  • Strong equity ratio
  • Strong operating profitability
  • Healthy short-term liquidity
Risk factors to note

No material separate warning signals.

Rating historyAutomatic assessment developmentChanges are derived from evidence differences between persisted automatic assessments.
5 assessments
A1
2026-09-19 17:3490/100 · v0.14
A3 → A1 · +17 points
  • Evidence strengthened: a PRH/XBRL financial statement was added to the assessment (2025-12-31).
  • Assessment confidence: Medium → High.
  • Evidence quality: Registry and statistical evidence → Strong financial evidence.
A3
2026-09-1473/100 · v0.14
A3 → A3
A3
2026-09-1473/100 · v0.13
B1 → A3 · +10 points
  • Assessment confidence: Low → Medium.
  • Evidence quality: Registry and statistical evidence → Registry and statistical evidence.
  • New risk factor: Sufficient structured financial metrics are not available.
B1
2026-09-1363/100 · v0.12
Oldest retained automatic assessment in this comparison
Automatic model gradeA1
Automatic model snapshot2026-09-19
Automatic model versionopen-risk-grade-v0.14
Financial data included

The grade can use open digital financial statement data together with registry signals.

Verify assessment

Risk context

When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.

Industry riskvery low
92/100

Industry context is very low based on normalized open statistical inputs.

Age and continuityHyvä
60/100

The company has about 7 years of registry continuity.

Registry and status signalsSeurattava
64/100

Registry history, filing recency, and active register markings are still limited or mixed.

Events & news

Verified events and sourced external company news in one timeline.

Risk grade updatedRisk gradeEvidence verified
19 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade A3 → A1.
Risk grade updatedRisk gradeEvidence verified
14 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade A3.

Registry timeline

Trade register notifications shown on a timeline.

10 register eventsLatest event: 2026-04-28

Financial statements availability

Available financial statement periods and PRH source filings.

4 financial statement periodsLatest financial period: 2025-12-31

Profile source and ownership

Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.

This company profile has not been claimed yet

SL.Pharma Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.